Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares Russell 2000 BuyWrite ETF (NY:IWMW)

36.68 -0.10 (-0.27%)
Streaming Delayed Price Updated: 9:57 AM EDT, Mar 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iShares Russell 2000 BuyWrite ETF

< Previous 1 2 3 4 5 Next >
Lexeo Therapeutics Stock Rallies On Discussions With FDA To Expedite Friedreich’s Ataxia Drug Approval Process ↗
Via Stocktwits
Plug Power Names Insider Jose Luis Crespo As New CEO ↗
Via Stocktwits
White House Reportedly Denies Plans To Acquire Stake In Critical Metals ↗
Via Stocktwits
News headline image
Rocket Pharma Stock Gets A Price Target Cut After Withdrawing FDA Application For Rare Bone Marrow Disorder Gene Therapy ↗
The company said that the decision is based on business and strategic considerations and does not reflect concerns regarding the safety or efficacy profile of Fanskya. 
Via Stocktwits
Esperion Shares Rally After Patent Litigation Settlement For Cholesterol Drugs ↗
Via Stocktwits
Topics Intellectual Property
News headline image
Taysha Gene Therapies Stock Soars After FDA Grants Breakthrough Therapy Designation To Gene Therapy ↗
Taysha also announced that it has finalized alignment with the FDA on the protocol for the trial intended to support its application for approval of TSHA-102. 
Via Stocktwits
AMC Entertainment Stock Is Rising Today And There’s A Taylor Swift Angle – Find Out More ↗
Via Stocktwits
Oklo Stock Continues To Be The Talk Of The Town After Gaining 87% In A Month – Here’s How Retail Investors Responded ↗
Via Stocktwits
This Stock Nearly Doubled In A Month, And It Just Received A Fresh Price Target Hike By Roth Capital – Find Out More ↗
Via Stocktwits
News headline image
Harmony Biosciences Stock Slumps After Rare Genetic Disorder Drug Fails Late-Stage Study ↗
The company said on Wednesday that its drug did not meet the primary endpoint of the trial primarily due to a higher-than-expected placebo response rate. 
Via Stocktwits
News headline image
Actuate Therapeutics Stock Rises After Updating FDA Application For Lead Investigational Drug In Treating Pancreatic Cancer ↗
Actuate on Monday also said that its recent $17.25 million public offering provides an extended runway into the second half of 2026. 
Via Stocktwits
News headline image
Emergent BioSolutions Stock Rises After Receiving Fresh International Purchase Orders: Retail Says Stock Is ‘Significantly Undervalued’ ↗
The order encompasses multiple product offerings within Emergent’s medical countermeasures business, including countermeasures for threats posed by Smallpox, Anthrax, and Botulism. 
Via Stocktwits
Intellia Therapeutics Stock Gets A Price Target Hike From HC Wainwright – Check Out The Details ↗
Via Stocktwits
Replimune Stock Plunged 42% Today – Here’s Why ↗
Via Stocktwits
Cracker Barrel In Spotlight After Slew Of Price Target Cuts: Citi Says Q1 Began In A ‘Deep Traffic Hole’ Post Logo Change ↗
Via Stocktwits
Bloom Energy Stock Jumped 7% This Morning – Here’s What Happened ↗
Via Stocktwits
Why Is aTyr Stock Falling Today? ↗
Via Stocktwits
IonQ Stock Stokes Retail Optimism After Receiving Necessary Clearances For Oxford Ionics Acquisition: Retail Sees ‘Multitrillion Dollar Market Company’ ↗
Via Stocktwits
Krispy Kreme Stock Pops After FBI Director Kash Patel Reportedly Endorses It As A ‘Good Investment’: Retail Chatter Soars Over 600% ↗
Via Stocktwits
News headline image
Why Is New Fortress Energy Stock Rising Today? ↗
The stock gained 23% before the bell on Wednesday after Puerto Rico's Governor Jenniffer Gonzalez announced that the company has reached a new agreement valued at approximately $4 billion to supply LNG... 
Via Stocktwits
Topics Energy
News headline image
Dave & Buster’s Sees Wall Street Downgrades, Yet Retail Sentiment Red-Hot ↗
UBS said that while Dave & Buster’s was still in the early stages of a turnaround, with macro pressure remaining elevated and visibility limited, an eventual return to consistently positive same-store... 
Via Stocktwits
News headline image
Sellas Life Sciences Stock In Spotlight After Institutional Investor Exercises Existing Warrants ↗
In consideration for the immediate exercise of the warrants in full, the institutional investor will receive new, unregistered warrants in a private placement to purchase up to 19.69 million shares of... 
Via Stocktwits
Wolfpack Research Reveals Short Position In EV Maker Faraday Future ↗
Via Stocktwits
Maze Therapeutics Stock Just Shot Up 24% Pre-Market Today – Here’s What Happened ↗
Via Stocktwits
Rapport Therapeutics Stock Rockets 204% Pre-Market To Head Toward All-Time Highs – Here’s What Happened ↗
Via Stocktwits
Immunome Stock Rises After Craig-Hellum Initiates Coverage With $26 Price Target: Here’s Why The Analyst Sees An ‘Attractive Entry Point’ ↗
Via Stocktwits
News headline image
Soleno Therapeutics Stock Tanks After Patient Treated With Drug Dies – More Details Inside ↗
Soleno said that its assessment of the death is the same as the treating physician, who said that the death is not related to the treatment with Vykat XR. 
Via Stocktwits
Topics Death
News headline image
Hedge Fund Reportedly Prepares To Launch Board Fight At OraSure Technologies: Retail Investors Believe It’s Good News ↗
Altai Capital Management is one of the largest owners of OraSure and has increased its stake from 3% at the end of June to 5% in recent weeks, in an effort to press for board representation, Reuters... 
Via Stocktwits
News headline image
Agios Pharma Stock Slumped 15% Today But Company Remains Top Pick For This Analyst – Find Out More ↗
While the FDA was originally expected to decide on the company’s application for Pyrukynd in treating thalassemia by September 7, its decision is now expected by December 7. 
Via Stocktwits
Novavax COVID-19 Vaccine Approved In Japan, Triggers Milestone Payment From Partner Takeda ↗
Via Stocktwits
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.